17-hydroxyprogesterone
17 Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double blind, randomized clinical trial
9
Screening for Congenital Adrenal Hyperplasia: The Delfia Screening Test Overestimates Serum 17-Hydroxyprogesterone in Preterm Infants
5
Plasma Progesterone and 17 hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia
11
Plasma 17 hydroxyprogesterone/cortisol ratio is not a predictor of systemic hypotension in extremely premature infants
7
Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants
10
Management of Congenital Adrenal Hyperplasia Using Serum Dehydroepiandrosterone Sulfate and 17-Hydroxyprogesterone Concentrations
7
Intramuscular 17 hydroxyprogesterone caproate to prevent preterm birth among HIV infected women in Zambia: study protocol of the IPOP randomized trial
9
Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study
8
The Effects of Gestational Age and Birth Weight on False-Positive Newborn-Screening Rates
9
Problem Solving in Clinical Endocrinology
12
In Vitro Hydroxylation of Steroids by Whole Adrenal Homogenates of Beef, Normal Man, and Patients with the Adrenogenital Syndrome
7
Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study
8
Blood levels and production rate of 17 hydroxypregnenolone in man
10
The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial
5
Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report
6
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
9
PubMedCentral-PMC5774863.pdf
13
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
12
Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety
10
Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases
13